ACS (excluding AMI): 1 trials - Prandoni
| aspirin + dipyridamol vs placebo | No demonstrated result |
All type of patients: 13 trials - Brooks - Mayo-A - Pantely - Wadsworth - Brussels - Basel - Leeds-B - Czech - Thaulow - Des Moines - Toronto dipyridamole - Ekestrom - GESIC (aspirin+dipyridamol)
| aspirin + dipyridamol vs control | No demonstrated result | |
| aspirin + dipyridamol vs placebo | No demonstrated result | |
| dipyridamol vs control | No demonstrated result | |
| dipyridamol vs placebo | No demonstrated result |
Secondary prevention in patients with CAD: 13 trials - PARIS - PARIS-II - PARIS - Atlanta (Sbar) - Becker - Wirecki - Igloe - Zion - Kinsella - Leiberman - Dewar - Neumann - Foulds
| dipyridamol vs control | No demonstrated result | |
| dipyridamol vs placebo | No demonstrated result | |
| dipyridamol + aspirin vs aspirin | No demonstrated result | |
| dipyridamol + aspirin vs placebo | No demonstrated result suggested Non fatal MI by 31% (not demonstrated) suggested stroke (fatal and non fatal) by 39% (not demonstrated) |
All type of patients: 13 trials - PARIS - PARIS-II - PARIS - Atlanta (Sbar) - Becker - Wirecki - Igloe - Zion - Kinsella - Leiberman - Dewar - Neumann - Foulds
| dipyridamol vs control | No demonstrated result | |
| dipyridamol vs placebo | No demonstrated result | |
| dipyridamol + aspirin vs aspirin | No demonstrated result | |
| dipyridamol + aspirin vs placebo | No demonstrated result suggested Non fatal MI by 31% (not demonstrated) suggested stroke (fatal and non fatal) by 39% (not demonstrated) |
All type of patients: 4 trials - Schwartz (Toronto) - White (aspirin+dipiridamol) - Nye (Dunedin) - Mayo-PTCA
| aspirin + dipyridamol vs placebo | No demonstrated result |
All type of patient: 3 trials - Hess (2) - Schoop (2) - VA study
| aspirin + dipyridamol vs placebo | No demonstrated result |
All type of patient: 3 trials - PARIS - PARIS-II - PARIS
| dipyridamol + aspirin vs aspirin | No demonstrated result | |
| dipyridamol + aspirin vs placebo | No demonstrated result suggested Non fatal MI by 31% (not demonstrated) suggested stroke (fatal and non fatal) by 39% (not demonstrated) |
All type of patient: 10 trials - Atlanta (Sbar) - Becker - Wirecki - Igloe - Zion - Kinsella - Leiberman - Dewar - Neumann - Foulds
| dipyridamol vs control | No demonstrated result | |
| dipyridamol vs placebo | No demonstrated result |
All type of patients: 12 trials - Parodi I - Parodi II - Zekert-III - Australian I - Australian II - Encke IA - Encke IB - Toulouse I - Harjola DVT - Weiss - Lyon-I - Hamburg
| aspirin + dipyridamol vs no treatment | No demonstrated result | |
| aspirin + dipyridamol vs placebo | No demonstrated result | |
| dipyridamol + aspirin vs control | No demonstrated result suggested Deep vein thrombosis by 50% (not demonstrated) | |
| dipyridamol + aspirin vs placebo | No demonstrated result |
-
About
-
Browse pathology
|
treatment
-
Site map
-
Credits
Made with in Lyon
-
Contact us
-
Privacy policy
-
